IP Patent News
 

'European' Tag

  • * PDL says gets Genentech letter on European patents – Reuters

    August 16, 2010

    Town Hall* PDL says gets Genentech letter on European patentsReutersO), which licenses its technology to Genentech, said the biotech giant has claimed its drugs do not infringe PDL’s European patents, throwing into doubt …PDL tumbles; Trubion rallies on buyout offerMarketWatchPDL BioPharma tumbles on patent dispute. FDA approves “morning after” pillBioMedReports (subscription)PDL BioPharma Receives Letter from [...]

  • Broccoli, tomatoes in landmark patent case – AFP

    July 21, 2010

    SAMAA TVBroccoli, tomatoes in landmark patent caseAFPMUNICH, Germany ‘

  • Monsanto Loses After EU Court Decides that Soy Meal No Longer Has Functional DNA

    July 8, 2010

    [Story ID: 2728] The European Court of Justice in Luxembourg ruled against Monsanto Co. stating that ‘

  • EPO Sees Double (Patenting)

    June 2, 2010

    [Story ID: 2134] If an authority grants two patents for the same invention to the same applicant, that is double patenting. In most European states the law requires that one of the patents must cease. Since it started, the European Patent Office (EPO) official view has been that it should not allow double patenting. The [...]

  • EpiCept announces U.K. launch of Ceplene

    April 20, 2010

    [Story ID: 1405] EpiCept Corporation today announced that the commercial launch of CepleneĀ® (histamine dihydrochloride) will take place in the United Kingdom on April 20, 2010 in conjunction with the British Society for Haematology 50th Annual Scientific Meeting in Edinburgh, Scotland. Ceplene is approved in the European Union for the remission maintenance and prevention of [...]

  • BIOTRONIK receives European approval for new ProMRI Pacing Systems

    April 8, 2010

    [Story ID: 1198] BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems ‘

  • Pluristem Therapeutics receives European Patent on core 3D cell expansion technology (News-Medical-Net)

    March 23, 2010

    [Story ID: 960] Pluristem Therapeutics Inc. today announced that it has been granted a European Patent on its core 3D cell expansion technology. The granting of the European patent follows the issuance of several corresponding US patents as well as corresponding patents in ten additional jurisdictions.

  • Just a Reminder: EPO Fees Increase April 1

    February 22, 2010

    [Story ID: 542] The European Patent Office (“EPO”) recently announced that most of its fees will increase by between 5 and 8 per cent from April 1, 2010.Ā  A summary of the new fees is shown here. What does this all mean to you? If you know that you want to enter the European regional [...]

  • Changes in the Implementing Rules of the European Patent Convention (EPC)

    February 2, 2010

    [Story ID: 163] The Administrative Council of the EPO decided, in March 2009, to make significant changes to the Implementing Rules of the European Patent Convention (EPC). These changes will enter into force on April 1, 2010 and will have a significant impact on the grant procedure before the EPO. Introduction of a new time [...]

 
ABOUT | CONTACT | ip-patent-news.com 2007 - 2010